Dr.ย Matthewย Ng
MBBS (London), MRCP (UK), PhD (UK)
Senior Consultant & Head of Department of GI Oncology
corporate_fareNational Cancer Centre Singapore
Matthew Ng
MBBS (London), MRCP (UK), PhD (UK)
Dr. Matthew Ng Chau Hsien is a Senior Consultant and Head of the Department of GI Oncology at the National Cancer Centre Singapore (NCCS), with a specialised clinical and research focus in gastrointestinal cancers. He holds academic appointments as Clinical Associate Professor at Duke-NUS Medical School and within the SingHealth Duke-NUS Oncology Academic Clinical Programme.
Dr. Ng's clinical practice spans the full breadth of gastrointestinal oncology, including colorectal cancer, gastric and oesophageal cancer, pancreatic cancer, liver cancer, bile duct and biliary tract cancers, and peritoneal-based malignancies. He leads upper GI cancer services at SingHealth and serves as Director of the Investigational Medicine Unit, overseeing early-phase clinical trials at NCCS. His research interests centre on novel therapeutics for GI cancers, biomarker-driven treatment development, and peritoneal-directed therapy strategies. Dr. Ng co-chairs the GI cancers service line delivery within the SingHealth Academic Medical Health Cluster and chairs the Named Patient Programme at NCCS. He is a member of the Singapore Gastric Cancer Consortium, the Singapore Peritoneal Oncology Study Group, and the Singapore Translational Cancer Consortium GI and Early Phase Trials track.
CancerFax can coordinate medical-record review, case preparation, and consultation support for international patients seeking an opinion from Dr. Matthew Ng at the National Cancer Centre Singapore.
Why Consider Dr. Matthew Ng?
Dr. Matthew Ng combines leadership of Singapore's foremost GI oncology department with an active research programme in early-phase trials, biomarker development, and novel therapeutic strategies โ making him a highly relevant specialist for patients with complex or advanced gastrointestinal cancers.
Areas of Specialisation
Focused expertise across the full spectrum of gastrointestinal cancers, peritoneal disease, and early-phase oncology drug development
Dr. Matthew Ng's specialisation covers lower and upper gastrointestinal cancers, hepatobiliary malignancies, peritoneal-based disease, and early-phase clinical research. His clinical and academic work spans systemic therapy, biomarker-driven treatment, and novel GI cancer strategies.
Lower GI & Colorectal Oncology
Systemic therapy and multidisciplinary management for colorectal cancer.
- arrow_rightSystemic therapy planning for localised and metastatic colorectal cancer
- arrow_rightBiomarker-guided treatment selection including MSI, KRAS, BRAF, and HER2 status
- arrow_rightPeritoneal metastasis management in colorectal cancer
Upper GI Cancers
Leadership of upper GI cancer services at SingHealth, with a focus on gastric, oesophageal, and gastroesophageal junction cancers.
- arrow_rightSystemic and targeted therapy for gastric and gastroesophageal junction adenocarcinoma
- arrow_rightHER2-positive gastric cancer treatment including margetuximab and pembrolizumab combinations
- arrow_rightPan-Asian clinical practice guideline contributor for metastatic gastric cancer
- arrow_rightSystemic treatment for oesophageal squamous cell carcinoma and adenocarcinoma
- arrow_rightPan-Asian adapted ESMO guideline contributor for metastatic oesophageal cancer
Hepatopancreaticobiliary Cancers
Medical oncology for cancers of the liver, pancreas, and biliary tract.
- arrow_rightSystemic therapy for advanced pancreatic adenocarcinoma
- arrow_rightPhase I trial participation in novel pancreatic cancer drug development (OXIRI regimen)
- arrow_rightHepatocellular carcinoma management including radioembolisation with Y90 and immunotherapy combinations
- arrow_rightBiliary tract and bile duct cancer systemic therapy
Peritoneal-Based Malignancies
Specialist management of peritoneal disease arising from GI primary cancers.
- arrow_rightPeritoneal metastases from colorectal, gastric, and other GI primaries
- arrow_rightPeritoneal-directed therapy development and research through the Singapore Peritoneal Oncology Study Group
Procedures & Clinical Services
Treatment approaches and investigational programmes offered through the National Cancer Centre Singapore
Dr. Matthew Ng provides medical oncology services for the full range of gastrointestinal cancers, with particular expertise in systemic therapy, targeted therapy, and early-phase clinical trial administration through the Investigational Medicine Unit at SingHealth.
Systemic Therapy for GI Cancers
Medical OncologyComprehensive systemic treatment planning and administration for all major gastrointestinal malignancies.
Targeted Therapy and Immunotherapy
Targeted TherapyMolecularly targeted and immunotherapy-based treatment for eligible GI cancer patients.
Early-Phase Clinical Trials
Complex DiseaseAccess to novel investigational agents and early-phase studies through the SingHealth Investigational Medicine Unit.
Multidisciplinary Tumour Board Review
MultidisciplinaryComplex GI cancer cases reviewed within a multidisciplinary team framework at NCCS and SingHealth.
Second Opinion for GI Cancers
Second OpinionExpert second-opinion review for patients with gastrointestinal cancers seeking assessment from a Singapore-based GI oncology specialist.
Research & Publications
Clinical research in gastrointestinal oncology, early-phase trials, and biomarker-driven treatment development
Dr. Matthew Ng has an active publication record in gastrointestinal oncology, with contributions to landmark studies in gastric, oesophageal, colorectal, and hepatocellular carcinoma. His research focuses on early-phase clinical trials incorporating biomarker analyses, biomarker development for GI cancer diagnostics and therapeutics, and novel therapeutic strategies for upper GI and peritoneal disease.
Dr. Ng directs the Investigational Medicine Unit at SingHealth. Patients with advanced GI cancers may be eligible for early-phase investigational studies. CancerFax can assist with case preparation for assessment.
Education & Training
Dr. Matthew Ng completed his undergraduate medical training in London, obtained Membership of the Royal College of Physicians in the United Kingdom, and earned a PhD from the Institute of Cancer Research, University of London.
Clinical Experience
Dr. Matthew Ng has built his entire specialist career in GI oncology at the National Cancer Centre Singapore and the SingHealth Academic Medical Health Cluster, rising to lead Singapore's GI oncology department and its early-phase clinical trial unit.
Languages & International
Dr. Matthew Ng consults in the following language.
CancerFax can coordinate professional medical interpreter support for international patients consulting at the National Cancer Centre Singapore.
CancerFax can coordinate professional medical interpreter support for international patients requiring consultation in other languages.
How CancerFax Helps You Access Dr. Matthew Ng
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Matthew Ng's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Matthew Ng's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Matthew Ng before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Matthew Ng's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Matthew Ng's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Matthew Ng's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Matthew Ng
Dr. Matthew Ng is a gastrointestinal oncology specialist. He treats colorectal cancer, gastric cancer, oesophageal cancer, pancreatic cancer, liver cancer, bile duct cancer, biliary tract cancer, and peritoneal-based malignancies. He leads upper GI cancer services at SingHealth and is Head of the Department of GI Oncology at the National Cancer Centre Singapore.
Dr. Matthew Ng's verified current affiliation is the National Cancer Centre Singapore (NCCS), where he is listed as Senior Consultant and Head of the Department of GI Oncology. He also holds an academic appointment as Clinical Associate Professor at Duke-NUS Medical School within the SingHealth Duke-NUS Oncology Academic Clinical Programme.
The National Cancer Centre Singapore provides an appointment pathway for patients including international visitors. CancerFax can coordinate medical-record preparation, case review, and consultation support for international patients seeking an opinion from Dr. Matthew Ng, subject to hospital availability and case acceptance.
You can submit your medical records and reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the hospital, subject to availability. A second-opinion request should include pathology reports, imaging, relevant tumour marker results, and prior treatment history.
Yes. Dr. Ng serves as Director of the Investigational Medicine Unit at SingHealth, overseeing early-phase clinical trials for gastrointestinal cancers. He has participated in trials evaluating novel agents for gastric, oesophageal, pancreatic, and hepatocellular carcinoma. Patients with advanced or refractory GI cancers may be assessed for trial eligibility. CancerFax can assist with case preparation for evaluation.
Dr. Matthew Ng holds MBBS (London) from St. Bartholomew's and the Royal London Hospital School of Medicine and Dentistry, Membership of the Royal College of Physicians (MRCP, UK), and a PhD from the Institute of Cancer Research, University of London. He received multiple academic prizes during his undergraduate training including the Brackenbury and Bourne Scholarship and the Draper's Prize.
Connect with Matthew Ng Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.